353 related articles for article (PubMed ID: 25423571)
1. Accelerated intestinal glucose absorption in morbidly obese humans: relationship to glucose transporters, incretin hormones, and glycemia.
Nguyen NQ; Debreceni TL; Bambrick JE; Chia B; Wishart J; Deane AM; Rayner CK; Horowitz M; Young RL
J Clin Endocrinol Metab; 2015 Mar; 100(3):968-76. PubMed ID: 25423571
[TBL] [Abstract][Full Text] [Related]
2. Effects of intraduodenal hydroxycitrate on glucose absorption, incretin release, and glycemia in response to intraduodenal glucose infusion in health and type 2 diabetes: A randomised controlled trial.
Thazhath SS; Wu T; Bound MJ; Checklin HL; Standfield S; Jones KL; Horowitz M; Rayner CK
Nutrition; 2016 May; 32(5):553-9. PubMed ID: 26792024
[TBL] [Abstract][Full Text] [Related]
3. Effects of metoclopramide on duodenal motility and flow events, glucose absorption, and incretin hormone release in response to intraduodenal glucose infusion.
Kuo P; Bellon M; Wishart J; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
Am J Physiol Gastrointest Liver Physiol; 2010 Dec; 299(6):G1326-33. PubMed ID: 20829521
[TBL] [Abstract][Full Text] [Related]
4. Effects of physiological hyperglycemia on duodenal motility and flow events, glucose absorption, and incretin secretion in healthy humans.
Kuo P; Wishart JM; Bellon M; Smout AJ; Holloway RH; Fraser RJ; Horowitz M; Jones KL; Rayner CK
J Clin Endocrinol Metab; 2010 Aug; 95(8):3893-900. PubMed ID: 20501683
[TBL] [Abstract][Full Text] [Related]
5. Upregulation of intestinal glucose transporters after Roux-en-Y gastric bypass to prevent carbohydrate malabsorption.
Nguyen NQ; Debreceni TL; Bambrick JE; Chia B; Deane AM; Wittert G; Rayner CK; Horowitz M; Young RL
Obesity (Silver Spring); 2014 Oct; 22(10):2164-71. PubMed ID: 24990218
[TBL] [Abstract][Full Text] [Related]
6. Selective sodium-dependent glucose transporter 1 inhibitors block glucose absorption and impair glucose-dependent insulinotropic peptide release.
Dobbins RL; Greenway FL; Chen L; Liu Y; Breed SL; Andrews SM; Wald JA; Walker A; Smith CD
Am J Physiol Gastrointest Liver Physiol; 2015 Jun; 308(11):G946-54. PubMed ID: 25767259
[TBL] [Abstract][Full Text] [Related]
7. Concurrent duodenal manometric and impedance recording to evaluate the effects of hyoscine on motility and flow events, glucose absorption, and incretin release.
Chaikomin R; Wu KL; Doran S; Jones KL; Smout AJ; Renooij W; Holloway RH; Meyer JH; Horowitz M; Rayner CK
Am J Physiol Gastrointest Liver Physiol; 2007 Apr; 292(4):G1099-104. PubMed ID: 17204542
[TBL] [Abstract][Full Text] [Related]
8. Comparative effects of variations in duodenal glucose load on glycemic, insulinemic, and incretin responses in healthy young and older subjects.
Trahair LG; Horowitz M; Rayner CK; Gentilcore D; Lange K; Wishart JM; Jones KL
J Clin Endocrinol Metab; 2012 Mar; 97(3):844-51. PubMed ID: 22238398
[TBL] [Abstract][Full Text] [Related]
9. Mechanisms Regulating Insulin Response to Intragastric Glucose in Lean and Non-Diabetic Obese Subjects: A Randomized, Double-Blind, Parallel-Group Trial.
Meyer-Gerspach AC; Cajacob L; Riva D; Herzog R; Drewe J; Beglinger C; Wölnerhanssen BK
PLoS One; 2016; 11(3):e0150803. PubMed ID: 26942445
[TBL] [Abstract][Full Text] [Related]
10. Impaired incretin effect and fasting hyperglucagonaemia characterizing type 2 diabetic subjects are early signs of dysmetabolism in obesity.
Knop FK; Aaboe K; Vilsbøll T; Vølund A; Holst JJ; Krarup T; Madsbad S
Diabetes Obes Metab; 2012 Jun; 14(6):500-10. PubMed ID: 22171657
[TBL] [Abstract][Full Text] [Related]
11. Gastric emptying, incretin hormone secretion, and postprandial glycemia in cystic fibrosis--effects of pancreatic enzyme supplementation.
Kuo P; Stevens JE; Russo A; Maddox A; Wishart JM; Jones KL; Greville H; Hetzel D; Chapman I; Horowitz M; Rayner CK
J Clin Endocrinol Metab; 2011 May; 96(5):E851-5. PubMed ID: 21389144
[TBL] [Abstract][Full Text] [Related]
12. Minor Contribution of Endogenous GLP-1 and GLP-2 to Postprandial Lipemia in Obese Men.
Matikainen N; Björnson E; Söderlund S; Borén C; Eliasson B; Pietiläinen KH; Bogl LH; Hakkarainen A; Lundbom N; Rivellese A; Riccardi G; Després JP; Alméras N; Holst JJ; Deacon CF; Borén J; Taskinen MR
PLoS One; 2016; 11(1):e0145890. PubMed ID: 26752550
[TBL] [Abstract][Full Text] [Related]
13. Comparative Effects of Proximal and Distal Small Intestinal Glucose Exposure on Glycemia, Incretin Hormone Secretion, and the Incretin Effect in Health and Type 2 Diabetes.
Zhang X; Young RL; Bound M; Hu S; Jones KL; Horowitz M; Rayner CK; Wu T
Diabetes Care; 2019 Apr; 42(4):520-528. PubMed ID: 30765429
[TBL] [Abstract][Full Text] [Related]
14. Thirty days of resveratrol supplementation does not affect postprandial incretin hormone responses, but suppresses postprandial glucagon in obese subjects.
Knop FK; Konings E; Timmers S; Schrauwen P; Holst JJ; Blaak EE
Diabet Med; 2013 Oct; 30(10):1214-8. PubMed ID: 23663119
[TBL] [Abstract][Full Text] [Related]
15. Incretin hormone secretion in women with polycystic ovary syndrome: roles of obesity, insulin sensitivity, and treatment with metformin.
Svendsen PF; Nilas L; Madsbad S; Holst JJ
Metabolism; 2009 May; 58(5):586-93. PubMed ID: 19375579
[TBL] [Abstract][Full Text] [Related]
16. Initially more rapid small intestinal glucose delivery increases plasma insulin, GIP, and GLP-1 but does not improve overall glycemia in healthy subjects.
Chaikomin R; Doran S; Jones KL; Feinle-Bisset C; O'Donovan D; Rayner CK; Horowitz M
Am J Physiol Endocrinol Metab; 2005 Sep; 289(3):E504-7. PubMed ID: 15886226
[TBL] [Abstract][Full Text] [Related]
17. Patients With Long-QT Syndrome Caused by Impaired
Hyltén-Cavallius L; Iepsen EW; Wewer Albrechtsen NJ; Svendstrup M; Lubberding AF; Hartmann B; Jespersen T; Linneberg A; Christiansen M; Vestergaard H; Pedersen O; Holst JJ; Kanters JK; Hansen T; Torekov SS
Circulation; 2017 May; 135(18):1705-1719. PubMed ID: 28235848
[TBL] [Abstract][Full Text] [Related]
18. The effect of acute dual SGLT1/SGLT2 inhibition on incretin release and glucose metabolism after gastric bypass surgery.
Martinussen C; Veedfald S; Dirksen C; Bojsen-Møller KN; Svane MS; Wewer Albrechtsen NJ; van Hall G; Kristiansen VB; Fenger M; Holst JJ; Madsbad S
Am J Physiol Endocrinol Metab; 2020 Jun; 318(6):E956-E964. PubMed ID: 32182123
[TBL] [Abstract][Full Text] [Related]
19. Impact of gastric emptying and small intestinal transit on blood glucose, intestinal hormones, glucose absorption in the morbidly obese.
Nguyen NQ; Debreceni TL; Burgess JE; Bellon M; Wishart J; Standfield S; Malbert CH; Horowitz M
Int J Obes (Lond); 2018 Sep; 42(9):1556-1564. PubMed ID: 29453463
[TBL] [Abstract][Full Text] [Related]
20. Secretion of incretin hormones (GIP and GLP-1) and incretin effect after oral glucose in first-degree relatives of patients with type 2 diabetes.
Nauck MA; El-Ouaghlidi A; Gabrys B; Hücking K; Holst JJ; Deacon CF; Gallwitz B; Schmidt WE; Meier JJ
Regul Pept; 2004 Nov; 122(3):209-17. PubMed ID: 15491793
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
